Global Renal Biomarkers Market By Overview
A biomarker is a measurable pointer of a specific biological state and it gives a reflection of the stage of, or the presence of, a disease. Renal biomarkers can be used clinically to screen, monitor or diagnose certain kidney-related diseases. They are also used to guide molecularly targeted therapy or to assess therapeutic response.
Global Renal Biomarkers Market By Dynamics
Growing prevalence of various kidney-related diseases among individuals globally is the major factor driving the growth of the global renal biomarkers market. Chronic kidney disease (CKD) is a disorder that causes reduced kidney function over some time. It may develop over many years and lead to end-stage kidney disease (ESRD). It has become a massive public health issue that endures rising. As per the data published by the Global Burden of Disease Study, kidney disease was the 12th-most common cause of death, estimating for 1.1 million deaths globally in 2015. CKD mortality increased by 31.7% over the past decade, making it one of the fastest rising major causes of death, along with dementia and diabetes. It ranked as the 17th leading cause of global years loss of life, which was an increase of 18.4% since 2005. This is in contrast to other noncommunicable diseases, like chronic obstructive pulmonary disease and cardiovascular disease, where the global year's loss of life fell during the same period. The high prevalence of high blood pressure and diabetes, which are the leading causes of renal diseases, and rapid technological advancements in the field of genetics. Advancements in the field of genetic technology over the last decade have enlightened people's knowledge regarding genetic regulatory pathways related to renal biomarkers. Genetics analyses have become essential in clinical practice and research, due to rapid advances in genomic technologies. Moreover, with the development of computer technology, renal biomarkers testing has become extensively accessible and feasible to perform, even in small-sized laboratories, thus boosting the growth of the target market. However, issues related to regulatory and reimbursement systems may hamper the growth of the target market over the forecast period. Nevertheless, recent advances in genetics have created lucrative growth opportunities for the target market. These rapid developments in genetics led to the expansion of more advanced renal biomarkers for treating kidney diseases, which ultimately boosts the target market.
Global Renal Biomarkers Market By Segmentation
The global renal biomarkers market is segmented based on biomarker type, diagnostic technique, end-user, and region.
Based on biomarker type, the global renal biomarkers market is segmented into functional biomarker and up-regulated protein. Functional biomarker segment is further divided into serum creatinine, serum cystatin C, and urine albumin. Up-regulated protein segment is further divided into neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1, and INTERLEUKIN-18. Based on diagnostic technique, the target market is segmented into enzyme-linked immunosorbent assay, particle-enhanced turbidimetric immunoassay (PETIA), colorimetric assay, chemiluminescent enzyme immunoassay (CLIA), and others. Based on end-user, the global market is classified into a hospital, diagnostic laboratory, and other end users.
Based on the region the global renal biomarkers market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are estimated to remain the dominant markets for renal biomarkers owing to robust economic growth, high expenditure on health care, and high awareness and acceptance of novel diagnostic methods in the regions. Changing demographics in developing economies, such as, India, China, Brazil, and South Africa are projected to provide high growth opportunities for the global renal biomarkers market. Private and public health care expenditure in these countries is projected to witness high growth, which in turn, is likely to boost the growth of these markets. The rise in global per capita income, coupled with robust growth in health care expenditure drives the renal biomarkers market. Improving government reimbursement programs and health care infrastructure in the developed, as well as developing countries, are likely to provide growth opportunities to the target market over the forecast period.
Global Renal Biomarkers Market, By Biomarker Type:
- Functional Biomarker
- Serum Creatinine
- Serum Cystatin C
- Urine Albumin
- Up-regulated Protein
- Neutrophil Gelatinase-associated Lipocalin (NGAL)
- Kidney Injury Molecule-1
- INTERLEUKIN-18
Global Renal Biomarkers Market, By Diagnostic Technique:
- Enzyme-linked Immunosorbent Assay
- Particle-enhanced Turbidimetric Immunoassay (PETIA)
- Colorimetric Assay
- Chemiluminescent Enzyme Immunoassay (CLIA)
- Others
Global Renal Biomarkers Market, By End-user:
- Hospital
- Diagnostic Laboratory
- Other End Users
Global Renal Biomarkers Market, By Region:
-
-
- North America
- North America Renal Biomarkers Market, By Biomarker Type
- North America Renal Biomarkers Market, By Diagnostic Technique
- North America Renal Biomarkers Market, By End-user
- North America Renal Biomarkers Market, By Country
- The U.S.
- Canada
- Europe
- Europe Renal Biomarkers Market, By Biomarker Type
- Europe Renal Biomarkers Market, By Diagnostic Technique
- Europe Renal Biomarkers Market, By End-user
- Europe Renal Biomarkers Market, By Country
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Asia Pacific Renal Biomarkers Market, By Biomarker Type
- Asia Pacific Renal Biomarkers Market, By Diagnostic Technique
- Asia Pacific Renal Biomarkers Market, By End-user
- Asia Pacific Renal Biomarkers Market, By Country
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- North America
-
- Latin America
-
-
- Latin America Renal Biomarkers Market, By Biomarker Type
- Latin America Renal Biomarkers Market, By Diagnostic Technique
- Latin America Renal Biomarkers Market, By End-user
- Latin America Renal Biomarkers Market, By Country
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Middle East & Africa Renal Biomarkers Market, By Biomarker Type
- Middle East & Africa Renal Biomarkers Market, By Diagnostic Technique
- Middle East & Africa Renal Biomarkers Market, By End-user
- Middle East & Africa Renal Biomarkers Market, By Country
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
-
Global Renal Biomarkers Market By Key Players
The key players operating the global renal biomarkers market involves Abbott Laboratories, BioPorto Diagnostics A/S, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Pacific Biomarkers, BioMérieux, Beckman Coulter (Danaher Corporation), Randox Laboratories Ltd., and Siemens Healthineers. Prominent players operating in the target market are focusing on strategic partnerships as well as the launching of the products to gain a competitive edge in the target market. For instance, in February 2019, Spark Therapeutics Inc. and Roche declared a definitive merger agreement, which enables Roche to fully acquire Spark Therapeutics at a price of US$ 114.50 per share, in an all-cash transaction.
Global Renal Biomarkers Market By Key Issues Addressed
- What is the total revenue potential of the global renal biomarkers market?
- How that market is expected to grow during the study period?
- What are some of the major growth opportunities in the renal biomarkers market?
- Which companies are the major players in the renal biomarkers market?
Global Renal Biomarkers Market By Company Profile
-
-
- Abbott Laboratories
- Company Overview
- Abbott Laboratories
-
-
-
-
- Biomarker Type Portfolio
- Key Highlights
- Financial Performance
-
-
- BioPorto Diagnostics A/S
- F. Hoffmann-La Roche AG
- Thermo Fisher Scientific Inc.
- Pacific Biomarkers
- BioMérieux, Beckman Coulter (Danaher Corporation)
- Randox Laboratories Ltd.
- Siemens Healthineers
“*” marked represents similar segmentation in other categories in the respective section
Global Renal Biomarkers Market By Table of Contents
Global Renal Biomarkers Market
Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Industry Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for Renal Biomarkers Strategies
- Key Questions this Study will Answer
- Market Snippet, By Biomarker Type
- Market Snippet, By Diagnostic Technique
- Market Snippet, By End-user
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global Renal Biomarkers Market, By Biomarker Type, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Functional Biomarker
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Serum Creatinine
- Serum Cystatin C
- Urine Albumin
- Up-regulated Protein
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Neutrophil Gelatinase-associated Lipocalin (NGAL)
- Kidney Injury Molecule-1
- INTERLEUKIN-18
- Overview
- Global Renal Biomarkers Market, By Diagnostic Technique, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Enzyme-linked Immunosorbent Assay
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Particle-enhanced Turbidimetric Immunoassay (PETIA)
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Renal Biomarkers Market, By End-user, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Hospital
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Diagnostic Laboratory
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Other End Users
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Renal Biomarkers Market, By Region, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Biomarker Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Diagnostic Technique, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-user, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Biomarker Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Diagnostic Technique, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-user, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Biomarker Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Diagnostic Technique, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-user, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Biomarker Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Diagnostic Technique, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-user, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Biomarker Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Diagnostic Technique, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-user, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
-
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- BioPorto Diagnostics A/S
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- F. Hoffmann-La Roche AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Thermo Fisher Scientific, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Pacific Biomarkers
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- BioMérieux
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Beckman Coulter (Danaher Corporation)
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Randox Laboratories Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Siemens Healthineers
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Abbott Laboratories
-
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
Renal Biomarker Market report is segmented based biomarker type, diagnostic technique, end-user, and region.
Growing prevalence of various kidney-related diseases among individuals globally is the major factor driving the growth of the global renal biomarkers market.
North America and Europe are estimated to remain the dominant markets for renal biomarkers owing to robust economic growth
The key players operating in the Bike-Sharing Service market includes Abbott Laboratories, BioPorto Diagnostics A/S, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Pacific Biomarkers, BioMérieux, Beckman Coulter (Danaher Corporation), Randox Laboratories Ltd.